483 Document: Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy, Sep 27, 2019

FDANews 483 Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy Sep 27 2019 top
Norman K. Starks FDA Investigator Anthony J. Ladner FDA Investigator

On Sep 27, 2019, the FDA inspected Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy's Roselle site. Explore the inspectional observations.